I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaCalendarioSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Portrait de Douglas Glen Janzen
EtÓ : 53
Patrimonio pubblico : 993 197 USD
Principali societÓ : Perimeter Medical Imaging AI, Inc. - Neovasc Inc. - Aequus Pharmaceuticals Inc.
Riassunto 
Founder of Aequus Pharmaceuticals, Inc., Northview Ventures, Inc. and Northview Ventures & Associates General Partnership, Douglas Glen Janzen is an entrepreneur and businessperson who has been at the head of 9 different companies and currently is Chairman, President & Chief Executive Officer for Aequus Pharmaceuticals, Inc., President, Chief Executive Officer & MD at Northview Ventures, Inc., Managing Director at Northview Ventures & Associates General Partnership and Chairman of Lexington Biosciences Holdings Corp.

He is also on the board of 9 other companies.

Mr. Janzen previously held the position of Chairman of AbCellera Biologics, Inc., Chairman at Lexington Biosciences, Inc., Head of Research at Loewen, Ondaatje, McCutcheon Ltd., Analyst at Cormark Securities, Inc., President, Chief Executive Officer & Director at Correvio Pharma Corp. and President & Chief Business Officer at Bradmer Pharmaceuticals, Inc.

Douglas Glen Janzen received an undergraduate degree from the University of Saskatchewan and a graduate degree from the University of British Columbia.


Posti e reponsabilitÓ di Douglas Glen Janzen 
NomeTitolo Da
Perimeter Medical Imaging AI, Inc.
(Attrezzatura medica )
Director -
Neovasc Inc.
(Attrezzatura medica )
Independent Director 2005
Aequus Pharmaceuticals Inc.
(Prodotti farmaceutici)
President, Chief Executive Officer & Director 2013
Northview Ventures, Inc. President, Chief Executive Officer & MD -
Synaptive Medical, Inc. Director -
LifeSciences British Columbia Director & Managing Director -
Perimeter Medical Imaging, Inc. Director -
Synaptive Technologies Ltd. Director -
Transdermal Research Pharm Laboratories LLC Director 2013
Lexington Biosciences Holdings Corp. Chairman 2017
Alabaster Technologies, Inc. Director -
AmpHP, Inc. Director -
Northview Ventures & Associates General Partnership Managing Director 2014


Participazioni di Douglas Glen Janzen 
NomeAzioni%Valorizzazione
Aequus Pharmaceuticals Inc. (AQS)
(Prodotti farmaceutici)
11 953 8009,01%633 551 USD
Perimeter Medical Imaging AI, Inc. (PINK)
(Attrezzatura medica )
171 6500,28%353 599 USD
Neovasc Inc. (NVCN)
(Attrezzatura medica )
13 9650,021%6 047 USD


Douglas Glen Janzen: network personale 
Le notizie pi¨ lette 
11/05CATHIE WOOD: Il crollo di Coinbase spinge il fondo ARK di Wood più vicino al minimo pandemico
MR
12/05MASAYOSHI SON: SoftBank riporta una perdita netta di 13 miliardi di dollari nell'anno fiscale
MR
15/05ELON MUSK: Elon Musk afferma che il team legale di Twitter gli ha detto che ha violato un NDA
MR
12/05ELON MUSK: Il ritardo di Musk nel rivelare la quota di Twitter innesca la sonda della SEC - WSJ
MR
05/05LARRY ELLISON: Musk si assicura un finanziamento di oltre 7 miliardi di dollari da investitori tra cui Larry Ellison
MR
03/05Azioni in rialzo, rendimenti statunitensi al 3% mentre i mercati si preparano al rialzo della Fed
MR
04/05WARREN BUFFETT: Gli azionisti di Berkshire votano in modo schiacciante per mantenere Buffett presidente
MR
06/05JACK DORSEY: Block oscilla in perdita trimestrale mentre la spinta di bitcoin svanisce
MR
03/05ELON MUSK: Elon Musk prevede di rendere Twitter di nuovo pubblico più tardi -WSJ
MR
17/05Gli azionisti di JPMorgan votano la disapprovazione della retribuzione speciale dell'amministratore delegato Dimon
MR
Notizie esclusive


© 2022 People and Ownership :   
Douglas Glen Janzen : connessioni